###begin article-title 0
beta-Cell Hyperplasia Induced by Hepatic Insulin Resistance
###end article-title 0
###begin title 1
OBJECTIVE
###end title 1
###begin p 2
###xml 244 249 <span type="species:ncbi:10090">mouse</span>
Type 2 diabetes results from a combination of insulin resistance and impaired insulin secretion. To directly address the effects of hepatic insulin resistance in adult animals, we developed an inducible liver-specific insulin receptor knockout mouse (iLIRKO).
###end p 2
###begin title 3
RESEARCH DESIGN AND METHODS
###end title 3
###begin p 4
Using this approach, we were able to induce variable insulin receptor (IR) deficiency in a tissue-specific manner (liver mosaicism).
###end p 4
###begin title 5
RESULTS
###end title 5
###begin p 6
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 795 800 <span type="species:ncbi:10090">mouse</span>
###xml 1016 1020 <span type="species:ncbi:10090">mice</span>
iLIRKO mice presented progressive hepatic and extrahepatic insulin resistance without liver dysfunction. Initially, iLIRKO mice displayed hyperinsulinemia and increased beta-cell mass, the extent of which was proportional to the deletion of hepatic IR. Our studies of iLIRKO suggest a cause-and-effect relationship between progressive insulin resistance and the fold increase of plasma insulin levels and beta-cell mass. Ultimately, the beta-cells failed to secrete sufficient insulin, leading to uncontrolled diabetes. We observed that hepatic IGF-1 expression was enhanced in iLIRKO mice, resulting in an increase of circulating IGF-1. Concurrently, the IR-A isoform was upregulated in hyperplastic beta-cells of iLIRKO mice and IGF-1-induced proliferation was higher than in the controls. In mouse beta-cell lines, IR-A, but not IR-B, conferred a proliferative capacity in response to insulin or IGF-1, providing a potential explanation for the beta-cell hyperplasia induced by liver insulin resistance in iLIRKO mice.
###end p 6
###begin title 7
CONCLUSIONS
###end title 7
###begin p 8
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Our studies of iLIRKO mice suggest a liver-pancreas endocrine axis in which IGF-1 functions as a liver-derived growth factor to promote compensatory pancreatic islet hyperplasia through IR-A.
###end p 8
###begin p 9
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 674 675 671 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 837 838 834 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1056 1057 1053 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1058 1059 1055 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1483 1484 1474 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 686 691 <span type="species:ncbi:10090">mouse</span>
###xml 982 987 <span type="species:ncbi:10090">mouse</span>
###xml 1007 1011 <span type="species:ncbi:10090">mice</span>
###xml 1161 1165 <span type="species:ncbi:10090">mice</span>
###xml 1320 1324 <span type="species:ncbi:10090">mice</span>
Type 2 diabetes results from a combination of insulin resistance and impaired insulin secretion. Although there is some debate about the primary defect underlying type 2 diabetes, insulin resistance is the most relevant pathophysiological feature of the pre-diabetes state (1,2). Rodent studies have shown that insulin insensitivity in both classic and nonclassic insulin target tissues can play a role in the control of glucose homeostasis (3). Insulin resistance also produces a compensatory increase in insulin secretion generating hyperinsulinemia, and ultimately, it is the failure of the beta-cell that causes fasting hyperglycemia and development of type 2 diabetes (1). Several mouse models have been developed to study the contributions of insulin resistance in various tissues to the overall regulation of glucose homeostasis (4). Although total whole-body insulin resistance produced by complete deletion of the insulin receptor (IR) does not produce any major effect on mouse development, these mice die 1 week after birth from severe ketosis (5,6). Combined restoration of IR function in brain, liver, and pancreatic beta-cells rescues IR knockout mice from neonatal death, prevents diabetes in a majority of animals, and normalizes adipose tissue content, lifespan, and reproductive function. In contrast, mice with IR expression limited to brain or liver and pancreatic beta-cells are rescued from neonatal death but develop lipoatrophic diabetes and die prematurely (7).
###end p 9
###begin p 10
###xml 181 182 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 182 182 179 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9"/>
###xml 183 185 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 484 485 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 996 997 990 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 1196 1200 <span type="species:ncbi:10090">mice</span>
Based on studies using tissue-specific conditional knockout of IR, liver, brain, and beta-cells represent the key sites of insulin resistance in the development of type 2 diabetes (8-10). The liver-specific IR knockout (LIRKO) revealed that insulin resistance in liver is the most important for development of impaired glucose tolerance and fasting hyperglycemia. In addition, these mice also developed marked beta-cell hyperplasia, hyperinsulinemia, and decreased insulin clearance (8). With aging, however, the diabetes in these animals was corrected, suggesting some form of compensatory mechanism possibly linked to the very early onset of insulin resistance in these mice that limited understanding of the full impact of hepatic insulin resistance in the pathogenesis of type 2 diabetes. Moreover, these mice developed liver damage related to appearance of hyperplastic nodules that might have altered glucose production by the liver, leading to regression of the diabetic state with aging (8). To better address the role of adult hepatic insulin resistance in the pathogenesis of type 2 diabetes, we developed an inducible model for generating liver IR deficiency (iLIRKO) in young, weaned mice.
###end p 10
###begin title 11
RESEARCH DESIGN AND METHODS
###end title 11
###begin p 12
###xml 2 13 2 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(loxP/loxP)</sup>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 197 200 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 333 344 333 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(loxP/loxP)</sup>
###xml 654 656 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 168 183 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
IR(loxP/loxP) C57Bl/6 mice were created by homologous recombination using an IR gene targeting vector with lox P sites flanking exon four as previously described (11). Transgenic mice expressing a Cre recombinase transgene under the control of the Mx1 promoter/enhancer were purchased from Jackson Laboratory (Bar Harbor, ME). The IR(loxP/loxP) mice were crossed with Mx-Cre mice to obtain iLIRKO mice. After weaning, iLIRKO mice were injected intraperitoneally with poly-inositic-poly-cytidilic acid (500 mug/injection) to induce the interferon-alpha response and the consequent Mx1 promoter activation as described previously with minor modifications (12). Animals were housed in virus-free facilities on a 12-h light-dark cycle (on at 0700 h, off at 1900 h) and were fed with a standard rodent chow ad libitum. All animal experimentation described in this article was conducted in accordance with accepted standards of humane animal use as approved by the corresponding institutional committee.
###end p 12
###begin title 13
###xml 20 31 20 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(loxP/loxP)</sup>
###xml 32 47 <span type="species:ncbi:10090">transgenic mice</span>
Genotyping of the IR(loxP/loxP) transgenic mice.
###end title 13
###begin p 14
###xml 2 13 2 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(loxP/loxP)</sup>
###xml 205 209 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
IR(loxP/loxP) transgenic mice were genotyped by PCR. Tail DNA (100-200 ng) was amplified 30 cycles (40 s, 94degreesC; 40 s, 60degreesC; and 1 min, 75degreesC) by a thermal cycler. Two primers flanking the loxP site behind exon four of the IR were used: the forward primer (5'-GATGTGCACCCCATGTCTG-3') and the reverse primer (5'-CTGAATAGCTGAGACCACAG-3'). A 320-bp band was obtained for the floxed allele or a 280-bp band for the wild-type allele.
###end p 14
###begin title 15
###xml 26 41 <span type="species:ncbi:10090">transgenic mice</span>
Genotyping of the Mx1-Cre transgenic mice.
###end title 15
###begin p 16
###xml 8 23 <span type="species:ncbi:10090">transgenic mice</span>
Mx1-Cre transgenic mice were genotyped by PCR. Tail DNA (100-200 ng) was amplified 35 cycles (1 min, 94degreesC; 1 min, 60degreesC; and 1 min, 72degreesC) on a thermal cycler. To amplify the Mx1-Cre transgene (PCR product, 269 bp), primers SF-4 (5'-GCATAACCAGTGAAACAGCATTGCTG-3') and 69R (5'-GGACATGTTCAGGGATCGCCAGGCG-3') were used.
###end p 16
###begin title 17
Western blot analysis.
###end title 17
###begin p 18
###xml 39 41 39 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 909 913 <span type="species:ncbi:10090">mice</span>
###xml 954 959 <span type="species:ncbi:9606">human</span>
Tissues were homogenized as described (11). Western blot analyses of insulin signaling proteins were performed on liver, muscle, brown adipose tissue, and brain homogenates as previously described (13). The antibodies used were anti-IRbeta (Ab-4) from Oncogene (San Diego, CA), anti-PEPCK antibody provided by D.K. Granner (Vanderbilt University, Nashville, TN), anti-glucokinase antibody (a gift of S. Lenzen, Hannover Medical School, Hannover, Germany), anti-fatty acid synthase antibody (purchased from BD Transduction Laboratories, San Diego, CA), and anti-beta-actin antibody (Sigma-Aldrich, St. Louis, MO). Anti-IGF-1 antibody was purchased from Upstate Biotechnology (Lake Placid, NY). Anti-phospho-p70-S6-kinase (Thr 421/Ser 424), anti-phospho-p44/p42-MAPK (Thr202/Tyr204), anti-phospho-Akt (Ser 473) antibodies were purchased from Cell Signaling (Beverly, MA). For in vivo insulin signaling studies, mice were injected with 1 unit/kg body wt of human insulin (Novo Nordisk) into the peritoneal cavity. After 10 min, tissues were removed and immediately frozen in liquid nitrogen. Triplicate blots of samples from five individuals of each genotype were used. Densitometric analysis was performed using a GS-710 Imaging Densitometer, and signals were quantified using Quantity One software (Bio-Rad Laboratories, Hercules, CA).
###end p 18
###begin title 19
Analytical procedures.
###end title 19
###begin p 20
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
Insulin levels in serum were measured by RIA using mouse insulin as a standard (Linco Research, St. Charles, MO). Radioimmunoassay using mouse IGF-1 as a standard (Diagnostic Systems Laboratories, Webster, TX) measured IGF-1 levels in serum. Glucose tolerance and insulin tolerance tests were performed as previously described (14).
###end p 20
###begin title 21
Histological analysis.
###end title 21
###begin p 22
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 139 141 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 142 144 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
The immunohistochemical analysis of pancreata was performed as described (14). beta-Cell mass was evaluated by point-counting morphometry (15,16). Relative volumes were calculated for beta-cells, non-beta-cells, and exocrine tissue. Contaminating tissue (including adipose, lymph nodes, and intestines) was recorded to correct for the pancreatic weight. The beta-cell mass was then calculated by multiplying the relative beta-cell volume by the corrected pancreatic weight. Staining of liver sections with hematoxylin/eosin, periodic acid Schiff, and Masson reagents was performed using standard techniques.
###end p 22
###begin title 23
Real-time quantitative PCR for insulin receptor isoforms.
###end title 23
###begin p 24
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 631 644 631 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
The pancreatic islets were isolated from 6-month-old control and iLIRKO mice as previously described (10). Insulin receptor isoforms expression in isolated islets was analyzed by real-time quantitative PCR using Taqman probes (MGB "Assay on Demand" probes; Applied Biosystems) following the manufacturer's instructions. The comparative threshold cycle (Ct) method was used to calculate the relative expression. For quantification of gene expression, the target genes values were normalized to the expression of the endogenous reference (18S). Thus, the amount of target, normalized to 18S and relative to the control, is given by 2-DeltaDeltaCt [DeltaCt = Ct (target gene) - Ct (18S); DeltaDeltaCt = DeltaCt for any sample - DeltaCt for the control].
###end p 24
###begin title 25
Reconstitution of IRKO immortalized beta-cells with IR-A or -B isoforms by retroviral infection.
###end title 25
###begin p 26
###xml 74 76 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 250 252 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
IRKO beta-cells were generated in our laboratory as previously described (17). From these cells we reconstituted and characterized the expression of the IR-A isoform (Rec A) and IR-B isoform (Rec B) generating new cell lines as previously described (18).
###end p 26
###begin title 27
Measurement of glucose uptake in beta-cells.
###end title 27
###begin p 28
###xml 246 247 246 247 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 251 252 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
Cells were cultured to 80% confluence in 10% FBS-DMEM and then serum and glucose starved for 4-6 h. After that, 10 nmol/l insulin or 10 nmol/l IGF-1 were added to the wells for 30 min. Glucose uptake was measured by incubating cells with 2-deoxy-d-[1-3H]-glucose for the last 10 min in triplicate dishes from six independent experiments as previously described (19).
###end p 28
###begin title 29
Cell viability assays.
###end title 29
###begin p 30
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
Cells were plated in 12-multiwell plates and cultured in 10% FBS-DMEM until 40-50% of confluence was reached. Cells were deprived of serum for a minimum of 4 h and then treated with insulin (10 nmol/l), IGF-1 (10 nmol/l), or both for 24 h. Subsequently, the cells were washed with PBS and stained with violet crystal as described (17).
###end p 30
###begin title 31
Proliferation studies in isolated pancreatic islets and cultured beta-cells.
###end title 31
###begin p 32
###xml 220 221 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 321 323 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
DNA synthesis in isolated islets was estimated by determining BrdU incorporation using the Cell Proliferation ELISA kit (Roche Diagnostics, Mannheim, Germany). In cultured beta-cells, the DNA synthesis was estimated by [3H] thymidine incorporation into trichloroacetic acid-precipitable material as previously described (20).
###end p 32
###begin p 33
###xml 118 119 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 163 164 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All values are expressed as means +/- SEM. Data were compared by ANOVA with the Bonferroni post-test or the Student's t test. The level of significance was set at P < 0.05.
###end p 33
###begin title 34
RESULTS
###end title 34
###begin title 35
Progressive liver-specific insulin receptor deletion without liver dysfunction.
###end title 35
###begin p 36
###xml 60 71 60 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(loxP/loxP)</sup>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 1202 1208 1166 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1210 1222 1174 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panels</italic>
###xml 1471 1472 1435 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1642 1648 1606 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1650 1662 1614 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panels</italic>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 97 112 <span type="species:ncbi:10090">transgenic mice</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 354 359 <span type="species:ncbi:10090">mouse</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
###xml 1196 1200 <span type="species:ncbi:10090">mice</span>
###xml 1408 1412 <span type="species:ncbi:10090">mice</span>
###xml 1581 1585 <span type="species:ncbi:10090">mice</span>
###xml 1610 1614 <span type="species:ncbi:10090">mice</span>
To create an inducible liver-specific deletion of the IR, IR(loxP/loxP) mice (11) were bred with transgenic mice expressing a Cre recombinase transgene under the control of the Mx1 promoter/enhancer. Finally, we obtained mice that all carried two floxed IR alleles and were heterozygous for the Mx1-Cre transgene. Thus, these mice constituted the iLIRKO mouse strain. Given that the deletion of IR varied from approximately50-100%, mice were divided into three groups: ones with approximately50% of the normal receptor expression, a second group with mice bearing approximately25% of normal IR, and a third group containing mice with virtually no remaining IR. Ablation of IR was tissue specific because none of the other insulin target tissues was affected (results not shown). An important feature of the phenotype produced by fetal IR deletion (LIRKO) was the appearance of liver dysfunction and histological changes. However, hematoxylin-eosin staining in liver sections revealed no dysplastic or hyperplastic nodules in 6- and 12-month-old iLIRKO mice as compared with their respective controls. In addition, Masson staining showed no increase in collagen infiltration or fibrosis in iLIRKO mice (Fig. 1, upper panels). Regarding enzymes of hepatic glucose metabolism, postnatal deletion of IR caused a reduction of glucokinase protein expression and a dramatic loss of glycogen liver content in iLIRKO mice consistent with previous observations in the LIRKO model (8). However, the expression of phosphoenol pyruvate carboxykinase or fatty acid synthase genes in 6-month-old mice was unchanged in iLIRKO mice as compared with controls (Fig. 1, lower panels).
###end p 36
###begin p 37
###xml 115 116 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 246 257 246 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 271 282 271 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
###xml 373 375 373 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</italic>
###xml 437 448 437 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(loxP/loxP)</sup>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
Liver histology and metabolic gene expression in inducible liver-specific insulin receptor knockout (iLIRKO) mice. A: Periodic acid Schiff, hematoxylin-eosin (H/E), and Masson staining of liver sections from fed 6- and 12-month-old male control (upper panel) and iLIRKO (lower panel) mice. The images are representative of four independent experiments. Magnifications 20x. B: Protein extracts of liver from 6-month-old Wt (wild type), IR(loxP/loxP), and iLIRKO mice were analyzed by Western blot (WB) with anti-IR beta-chain, PEPCK, FAS (fatty acid synthase), GK, and beta-actin antibodies as indicated in each panel. The blots are representative of five independent experiments. The corresponding autoradiograms were quantitated by scanning densitometry and are expressed as mean +/- SEM. (A high-quality digital representation of this figure is available in the online issue.)
###end p 37
###begin title 38
Progressive insulin resistance and glucose intolerance in iLIRKO.
###end title 38
###begin p 39
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 551 557 551 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1011 1017 1011 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1765 1766 1765 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1942 1948 1942 1948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1950 1962 1950 1962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panels</italic>
###xml 2110 2116 2110 2116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 2118 2130 2118 2130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panels</italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 1265 1269 <span type="species:ncbi:10090">mice</span>
###xml 1328 1333 <span type="species:ncbi:10090">mouse</span>
###xml 1536 1540 <span type="species:ncbi:10090">mice</span>
###xml 1724 1728 <span type="species:ncbi:10090">mice</span>
###xml 1877 1881 <span type="species:ncbi:10090">mice</span>
###xml 1987 1991 <span type="species:ncbi:10090">mice</span>
In LIRKO mice, insulin signaling in vivo is selectively impaired in liver because these mice display normal insulin sensitivity in skeletal muscle (8). At 6 months of age, iLIRKO mice presented defects in insulin signaling, which were proportional to their loss of IR expression. Thus, in the group with 50% reduction in IR expression, there was a marked decrease in Akt, extracellular signal-related kinases (ERKs), and p70S6-kinase activation, whereas in the group with complete IR deletion, insulin was unable to activate these signaling pathways (Fig. 2). Interestingly, although our deletion strategy did not alter the levels of IR expression in other tissues (results not shown), we observed progressive impairment of insulin signaling in some peripheral tissues. Thus, in iLIRKO mice, there was a graded impairment of insulin-stimulated Akt and ERKs signaling in brain, skeletal muscle, or interscapular brown adipose tissue, the degree of which correlated with the severity of IR deletion in the liver (Fig. 2). Similarly, p70S6-kinase signaling was impaired in response to insulin in these tissues and was dependent as well on hepatic IR expression. Insulin signaling in both liver and these extrahepatic tissues was markedly impaired in 1-year-old iLIRKO mice (results not shown). Our results indicate that the iLIRKO mouse develops primary insulin resistance in the liver, and this is associated with secondary insulin resistance in peripheral tissues, which persists throughout the life of the animal. In conventional LIRKO mice, IR deletion induced severe insulin resistance, which caused glucose intolerance at 2 months of age, but this diabetic phenotype was completely reversed by 6 months of age when these mice presented normal glucose tolerance (8). In contrast, our strategy of deleting the IR after weaning induced progressive insulin resistance in iLIRKO mice from 2 to 6 months old and this persisted at 1 year of age (Fig. 3, upper panels). More importantly, the mice without liver IR displayed progressive glucose intolerance and even developed fasting hyperglycemia at 1 year of age (Fig. 3, lower panels).
###end p 39
###begin p 40
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">Mice</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
Inducible liver-specific insulin receptor knockout (iLIRKO) shows insulin resistance in the liver and extrahepatic tissues. In vivo insulin signaling studies were performed in 6-month-old control and iLIRKO mice. Mice of both experimental groups were injected with 1 unit/kg body wt of human insulin (Novo Nordisk) into the peritoneal cavity. After 10 min of treatment, liver, muscle, BAT (brown adipose tissue), and brain were removed. Protein extracts of these tissues were analyzed by Western blot (WB) with anti-IR beta-chain, phospho-Akt, phospho-p70, phospho-ERK1/2, and beta-actin antibodies. The results are representative of four independent experiments. Histograms summarize the densitometric analysis of the corresponding Western blots.
###end p 40
###begin p 41
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 519 520 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 531 533 529 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</italic>
###xml 912 913 908 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 942 943 938 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 954 955 950 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 306 311 <span type="species:ncbi:9606">human</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
Progressive insulin resistance and glucose intolerance in inducible liver-specific insulin receptor knockout (iLIRKO) mice. A: Insulin tolerance tests were performed on 2-, 4-, 6-, and 12-month-old male control (o) and iLIRKO (●) mice. Fed animals were injected intraperitoneally with 1 unit/kg body wt of human regular insulin. Blood glucose was measured immediately before injection and 15, 30, and 60 min after the injection. Results expressed as percentage of initial blood glucose concentration are means +/- SEM (n = 10-20). B: Glucose tolerance tests were performed on 2-, 4-, 6-, and 12-month old control (o) and iLIRKO (●) mice that had been fasted for 16 h. Animals were injected intraperitoneally with 2 g/kg body wt of glucose. Blood glucose was measured immediately before injection and 30, 60, 90, and 120 min after the injection. Results are expressed as mean blood glucose concentration +/- SEM; n = 10-20 of each genotype. **P < 0.005; *P < 0.05; iLIRKO versus control.
###end p 41
###begin title 42
Progressive beta-cell hyperplasia and failure of insulin secretion with aging.
###end title 42
###begin p 43
###xml 241 242 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 447 453 441 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 453 454 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 614 620 608 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 620 621 614 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 687 693 678 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 693 694 684 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 798 804 789 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 804 805 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 882 888 873 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 888 889 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1110 1111 1101 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 1032 1036 <span type="species:ncbi:10090">mice</span>
###xml 1172 1176 <span type="species:ncbi:10090">mice</span>
Previously, it was shown that constitutive LIRKO mice developed severe hyperinsulinemia and beta-cell hyperplasia by 2 months of age, and this fasting hyperinsulinemia remained unchanged although the glucose intolerance reverted with aging (8). In the present study, iLIRKO presented progressive beta-cell hyperplasia as compared with controls. More importantly, the level of hyperplasia was correlated to the level of IR expression in the liver (Fig. 4B). The iLIRKO mice also developed progressive hyperinsulinemia as compared with controls, and this also correlated with the extent of IR deletion in the liver (Fig. 4B). This beta-cell expansion persisted throughout life as shown in Fig. 4D. In parallel, plasma insulin increased by 2.5-fold in 1-year-old mice as compared with their controls (Fig. 4D); however, this increase was much lower than at 6 months of age (threefold, Fig. 4D), suggesting a failure of insulin secretion with aging. Additionally, insulin content in pancreas slides of 6-month-old and 1-year-old iLIRKO mice was quantified. The data revealed a 25% increase in the insulin content (P < 0.0001) in 1-year-old as compared with 6-month-old iLIRKO mice (results not shown).
###end p 43
###begin p 44
###xml 166 167 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 471 472 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 474 485 465 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 613 613 596 596 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="cjs2088.jpg" mimetype="image"/>
###xml 726 727 706 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 750 766 730 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lower left panel</italic>
###xml 866 866 841 841 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="cjs2088.jpg" mimetype="image"/>
###xml 975 992 948 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lower right panel</italic>
###xml 1090 1090 1058 1058 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="cjs2088.jpg" mimetype="image"/>
###xml 1220 1222 1186 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</italic>
###xml 1433 1434 1393 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1436 1447 1396 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 1617 1633 1571 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lower left panel</italic>
###xml 1800 1817 1752 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lower right panel</italic>
###xml 1982 1983 1932 1933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1994 1995 1944 1945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2012 2013 1962 1963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 1076 1080 <span type="species:ncbi:10090">mice</span>
###xml 1273 1277 <span type="species:ncbi:10090">mice</span>
###xml 1541 1545 <span type="species:ncbi:10090">mice</span>
###xml 1709 1713 <span type="species:ncbi:10090">mice</span>
###xml 1891 1895 <span type="species:ncbi:10090">mice</span>
Progressive IGF-1 liver expression, beta-cell hyperplasia, and defective insulin secretion with aging in inducible liver-specific insulin receptor knockout (iLIRKO). A: Liver extracts from 6-month-old control and iLIRKO mice with graded IR deletion were analyzed by Western blot with anti-IR beta-chain, IGF-1, IGFBP1, IGFBP3, and beta-actin antibodies. The Western blot autoradiograms of IGF-1 were quantified by scanning densitometry from four independent experiments. B, upper panel: beta-cell mass was evaluated by point-counting morphometry in 6-month-old control (square) and iLIRKO mice (mice with 50% IR, ; mice with 25% IR, ▤; mice with 0% IR, ■), results shown as fold increase of beta-cell mass in control animals, n = 7-15 of each group. Lower left panel: plasma insulin content was measured in 6-month-old male control (square) and iLIRKO mice (50% IR, ; 25% IR, ▤; 0% IR, ■) by RIA (Linco); values are expressed as means +/- SEM from four animals per genotype. Lower right panel: plasma IGF-1 content was measured in 6-month-old male control (square) and iLIRKO mice (50% IR, ; 25% IR, ▤; 0% IR, ■) by RIA (Diagnostic Systems Laboratories). Values expressed as mean +/- SEM from four animals per genotype. C: Liver extracts from 1-year-old control and iLIRKO mice were analyzed by Western blot with anti-IR beta-chain, IGF-1, IGFBP1, IGFBP3, and beta-actin antibodies. A representative experiment out of four is shown. D, upper panel: beta-cell mass was evaluated by point-counting morphometry in 1-year-old control and iLIRKO mice; results are presented as fold increase of the control beta-cell mass. Lower left panel: plasma insulin content was measured in 1-year-old male control and iLIRKO mice by RIA (Linco); values are expressed as means +/- SEM from four animals per genotype. Lower right panel: plasma IGF-1 content was measured in 1-year-old male control and iLIRKO mice by RIA (Linco); values are expressed as means +/- SEM from four animals per genotype.*P < 0.05, **P < 0.005, and ***P < 0.001 iLIRKO versus control.
###end p 44
###begin title 45
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Progressive hepatic expression and plasma concentration of IGF-1 in iLIRKO mice.
###end title 45
###begin p 46
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 382 388 382 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 555 561 555 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 561 562 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 730 736 730 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 742 743 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
Previous studies have suggested the presence of a circulating islet growth factor in insulin-resistant states independent of glucose and obesity (21). To address this important issue, we performed Western blot analysis of iLIRKO liver samples using anti-IGF-1 antibodies. We observed increases of IGF-1 expression that depended inversely on the level of IR expression in the liver (Fig. 4A). In parallel, IGFBP1 and IGFBP3 were also upregulated in iLIRKO mice depending on the extent of IR deletion in liver. These data were confirmed in 1-year-old mice (Fig. 4C). Interestingly, iLIRKO mice, which expressed no liver IR, had significantly increased levels of plasma IGF-1 at 6 months and 1 year of age as compared with controls (Fig. 4B and D, respectively).
###end p 46
###begin title 47
Increase of IR-A isoform in pancreatic islets: beta-cell lines expressing IR-A, but not IR-B, induce proliferation in response to insulin or IGF-1.
###end title 47
###begin p 48
###xml 137 143 137 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 299 305 299 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 680 686 680 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 686 687 686 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1022 1028 1016 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1028 1029 1022 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1182 1188 1176 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1188 1189 1182 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1295 1301 1289 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1301 1302 1295 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1510 1516 1501 1507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1516 1517 1507 1508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1746 1752 1734 1740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1752 1753 1740 1741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 2035 2041 2017 2023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 2041 2042 2023 2024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
###xml 858 863 <span type="species:ncbi:10090">mouse</span>
The IR expression in pancreatic islets, as estimated by real-time PCR, significantly increased in iLIRKO mice as compared with controls (Fig. 5A). More importantly, the percentage of IR-A isoform (IR-A) expressed in pancreatic islets dramatically increased in iLIRKO mice as compared with controls (Fig. 5A). To assess whether the balance of IR-A versus IR-B might alter the proliferation rate of islets, we analyzed BrdU incorporation in response to either 10 nmol/l insulin or 10 nmol/l IGF-1 in pancreatic islets of 6-month-old mice. The results demonstrated that IGF-1-induced proliferation was significantly higher in pancreatic islets from iLIRKO mice than in the controls (Fig. 5B). Previous reports suggest that IR-A was twofold more sensitive than IR-B in mediating glycogen synthesis and mitogenesis (22). To further explore these possibilities in mouse beta-cells, we generated beta-cell lines bearing IR (IRLoxP), lacking IR (IRKO), expressing exclusively IR-A (Rec A), or expressing exclusively IR-B (Rec B) (Fig. 5C). Cell lines expressing IR responded to 10 nmol/l insulin in contrast to cells lacking IR as determined by Western blot analysis of IR phosphorylation (Fig. 5D). Additionally, the four cell lines responded to 10 nmol/l IGF-1 as confirmed by IGF-1R phosphorylation (Fig. 5D). The lack of IR significantly decreased basal glucose uptake in beta-cells. Reconstitution with IR-A, but not with IR-B, restored basal glucose uptake to levels higher than those observed in control cells (Fig. 5E). Although either insulin or IGF-1 enhanced cell viability in control cells, only IGF-1 induced cell viability in beta-cells lacking IR. Rec A cells but not Rec B increased cell viability in response to either insulin or IGF-1 (Fig. 5F). When we assessed proliferation by thymidine incorporation, both insulin and IGF-1 increased proliferation in control beta-cells, whereas cell lines lacking IR did not respond to IGF-1. Finally, insulin and IGF-1 promoted proliferation in Rec A beta-cells but not in Rec B lines (Fig. 5G).
###end p 48
###begin p 49
###xml 164 165 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 345 372 342 369 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">research design and methods</sc>
###xml 412 413 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 438 439 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 450 451 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 464 465 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 495 497 490 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</italic>
###xml 838 838 833 833 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="cjs2088.jpg" mimetype="image"/>
###xml 1006 1007 999 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1087 1088 1080 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1130 1132 1123 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</italic>
###xml 1339 1341 1329 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D:</italic>
###xml 1581 1583 1568 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E:</italic>
###xml 1739 1739 1723 1723 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="cjs2088.jpg" mimetype="image"/>
###xml 1783 1810 1767 1794 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">research design and methods</sc>
###xml 1869 1870 1853 1854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1927 1928 1911 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1973 1975 1957 1959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F:</italic>
###xml 2108 2108 2089 2089 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="cjs2088.jpg" mimetype="image"/>
###xml 2318 2345 2299 2326 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">research design and methods</sc>
###xml 2401 2402 2382 2383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 2497 2498 2478 2479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2580 2581 2561 2562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2591 2593 2572 2574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G:</italic>
###xml 2726 2726 2704 2704 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="cjs2088.jpg" mimetype="image"/>
###xml 2908 2935 2886 2913 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">research design and methods</sc>
###xml 2991 2992 2969 2970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 3087 3088 3065 3066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 3170 3171 3148 3149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 1123 1127 <span type="species:ncbi:10090">mice</span>
Increase of IR-A isoform in pancreatic islets: beta-cell lines expressing IR-A (Rec A), but not IR-B (Rec B), induce proliferation in response to insulin or IGF-1. A: mRNA levels of insulin receptor and the insulin receptor isoforms distribution were analyzed by real-time quantitative PCR in 6-month-old control and iLIRKO mice as described in research design and methods. Values are expressed as mean +/- SEM; n = 4 of each genotype, (*P < 0.05; **P < 0.005; ***P < 0.001 iLIRKO vs. control). B: Pancreatic islet proliferation was assessed by BrdU incorporation in 6-month-old control and inducible liver-specific insulin receptor knockout (iLIRKO) mice. The islets were isolated as described and seeded in 96-well plates for 16 h in RPMI medium. After that, the medium was removed and fresh medium with the stimuli (10 nmol/l insulin, ; 10 nmol/l IGF-1, ▤) and BrdU was added for 24 h. Finally, the BrdU incorporation was measured as indicated by the manufacturer. Values are expressed as mean +/- SEM; n = 4 of each genotype. Data were subjected to ANOVA with Bonferroni post-test (*P < 0.05; IGF-1 vs. basal in iLIRKO mice). C: IR expression was analyzed by Western blot and RT-PCR in IRLoxP, IRKO, Rec A, and Rec B beta-cells. Arrow at the RT-PCR panels indicates the IR-A and IR-B. A representative experiment out of four is shown. D: Functional assessment of insulin receptor reconstitution was carried out by immunoprecipitation of insulin- or IGF-1-stimulated beta-cells with antibodies against IR or IGF-1R and subsequent Western blot against phospho-tyrosine residues. E: IRLoxP, IRKO, Rec A, and Rec B beta-cells were cultured to 80% confluence and then serum and glucose starved for 4-6 h. Glucose uptake induced by insulin () or IGF-1 (▤) was measured as described in research design and methods. Data were subjected to ANOVA with Bonferroni post-test (*P < 0.05, IRKO and Rec A vs. IRLoxP in basal conditions; #P < 0.05, IGF-1 vs. basal of each cell line). F: IRLoxP, IRKO, Rec A, and Rec B beta-cells were cultured to 50% confluence in 10% FBS-DMEM overnight. After that, 10 nmol/l insulin (), 10 nmol/l IGF-1 (▤), or both (■) were added to the wells in serum-starved 5 mmol/l glucose DMEM. After 24 h, the medium was withdrawn and the four cell lines were stained with violet crystal as described in research design and methods. Statistical significance was carried out by Student's t test by comparison of basal conditions with insulin-stimulated conditions of each cell line (*P < 0.05) or basal conditions with IGF-1-stimulated conditions of each cell line (#P < 0.05). G: IRLoxP, IRKO, Rec A, and Rec B beta-cells were cultured to 50% confluence in 10% FBS-DMEM overnight. After that, 10 nmol/l insulin (), 10 nmol/l IGF-1 (▤), or both (■) were added to the wells in serum-starved 5 mmol/l glucose DMEM for 24 h. Thymidine incorporation was measured in these conditions as described in research design and methods. Statistical significance was carried out by Student's t test by comparison of basal conditions with insulin-stimulated conditions of each cell line (*P < 0.05) or basal conditions with IGF-1-stimulated conditions of each cell line (#P < 0.05).
###end p 49
###begin title 50
DISCUSSION
###end title 50
###begin p 51
###xml 178 179 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 640 642 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
###xml 1509 1513 <span type="species:ncbi:10090">mice</span>
Insulin promotes both metabolism and growth in the liver. Constitutive ablation of IR in liver causes severe metabolic changes and a reduction of liver size by approximately50% (8). Likewise, mice in which there is variable IR deletion (cellular mosaicism) exhibit different degrees of growth retardation and metabolic abnormality depending on the extent of IR deletion. IR ablation in approximately80% of cells causes extreme growth retardation and lipoatrophy with beta-cell hyperplasia, whereas IR ablation in 98% of cells, although resulting in similar growth retardation and lipoatrophy, causes diabetes without beta-cell hyperplasia (23). These findings suggest that insulin regulates growth independently of metabolism and that the number of insulin receptors is an important determinant of the specificity of insulin action. In the present study, we have used an inducible strategy to generate IR deficiency in liver; thus, we obtained mice with variable levels of IR deletion (liver mosaicism). Based on this iLIRKO model, induction of liver IR deficiency after weaning caused progressive insulin resistance and glucose intolerance without alterations in liver growth. Under our experimental conditions, the effects of insulin on growth and metabolic regulation are mutually independent. Thus, deletion of liver IR in young adults gave rise to irreversible insulin resistance and progressive glucose intolerance, which persisted for up to 1 year, although liver damage was not observed in any iLIRKO mice.
###end p 51
###begin p 52
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
###xml 1291 1295 <span type="species:ncbi:10090">mice</span>
Previous studies with conditional knockouts and reconstitution models concluded that the progression of insulin resistance to diabetes with fasting hyperglycemia requires defects in tissues other than liver (7,8). Moreover, acute deletion of IR in the liver has been reported to impair insulin signaling but does not induce insulin resistance or hyperinsulinemia (24). Our results in iLIRKO demonstrate that liver-specific disruption of IR can impair both hepatic and extrahepatic insulin signaling and that the severity of this resistance depends on the extent of IR deletion in the liver. iLIRKO mice display early insulin resistance as a primary defect related directly to the reduction or ablation of liver IR, but they also have impaired insulin signaling in other peripheral tissues, including skeletal muscle and brain. Thus, iLIRKO mice present systemic insulin resistance as a secondary effect. Given that our deletion strategy did not alter IR expression in other tissues, this effect is likely the result of desensitization of the IR in extrahepatic tissues produced by prolonged hyperinsulinemia. Thus, our results demonstrate that a primary defect in the liver triggers secondary insulin resistance in extrahepatic tissues and suggest that the progression to diabetes in iLIRKO mice does not require defects other than liver IR deficiency.
###end p 52
###begin p 53
###xml 172 173 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 318 320 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 925 927 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
###xml 675 679 <span type="species:ncbi:10090">mice</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
Insulin resistance is associated with hyperinsulinemia and leads to beta-cell hyperplasia. Thus, total deletion of liver IR induced beta-cell hyperplasia in LIRKO animals (8). However, conditional inactivation of IR in muscle was not associated with either islet hyperplasia or elevated circulating levels of insulin (11). Our results with iLIRKO demonstrate a direct relationship between the level of IR expression remaining in the liver and the fold increase of plasma insulin levels and beta-cell mass. Finally, constitutive LIRKO mice displayed dysregulation of insulin secretion for more than 1 year. However, in iLIRKO mice, compensatory hyperinsulinemia in 1-year-old mice was much lower than in 6-month-old mice. Thus, in our model, a failure in insulin secretion by beta-cells seems to occur given the inhibition of insulin clearance in the liver, the major site where insulin is degraded in an IR-dependent manner (25). More importantly, the observations from iLIRKO suggest that owing to severe insulin resistance and prolonged hypersecretion of insulin, the beta-cells ultimately undergo a failure to secrete insulin.
###end p 53
###begin p 54
###xml 89 91 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 92 94 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 249 251 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 419 421 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 686 688 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 890 892 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1286 1288 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1548 1550 1527 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1666 1668 1645 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1669 1671 1648 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1672 1674 1651 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1904 1906 1883 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1907 1909 1886 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 2048 2050 2021 2023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 2182 2185 2155 2158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2190 2193 2163 2166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2255 2257 2225 2227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 2975 2977 2936 2938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 1084 1088 <span type="species:ncbi:10090">mice</span>
###xml 1360 1364 <span type="species:ncbi:10090">mice</span>
###xml 1612 1616 <span type="species:ncbi:10090">mice</span>
###xml 1696 1711 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1836 1851 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1934 1949 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2103 2107 <span type="species:ncbi:10090">mice</span>
###xml 2194 2198 <span type="species:ncbi:10090">mice</span>
###xml 2202 2207 <span type="species:ncbi:10090">mouse</span>
###xml 2465 2469 <span type="species:ncbi:10090">mice</span>
###xml 2592 2596 <span type="species:ncbi:10090">mice</span>
###xml 2810 2815 <span type="species:ncbi:10090">mouse</span>
###xml 3130 3134 <span type="species:ncbi:10090">mice</span>
###xml 3280 3284 <span type="species:ncbi:10090">mice</span>
###xml 3599 3603 <span type="species:ncbi:10090">mice</span>
###xml 3633 3637 <span type="species:ncbi:10090">mice</span>
Previous evidence demonstrated that insulin signaling is essential for beta-cell growth (10,26). Recently, double deficiency for IR in the liver and the beta-cells was unable to induce beta-cell hyperplasia in response to severe insulin resistance (27). In fact, the persistence of robust hyperplasia in 6-month-old hypoglycemic LIRKO mice supports the concept of a glucose-independent circulating islet growth factor (27). In this context, iLIRKO mice displayed increased liver IGF-1 expression dependent on the extent of IR deletion in the liver. This resulted in a persistent increase of plasma IGF-1, consistent with the fact that the liver is the main source of circulating IGF-1 (28). Previous data demonstrated that conditional deletion of IGF-1R in the beta-cell does not alter islet beta-cell mass growth, suggesting a role for this receptor in regulating differentiated function (29). Surprisingly, we have found a relationship between hyperinsulinemia and beta-cell hyperplasia based on an increase of genes related to beta-cell proliferation and differentiation in iLIRKO mice. Thus, IGF-1 signaling might be involved in the induction of genes related to glucose-stimulated insulin secretion, among others. IGFBPs regulate the systemic effects of IGF-1 in a complex manner (30). Interestingly, IGFBP1 was upregulated in parallel to IGF-1 in iLIRKO mice, effects that were dependent on the level of hepatic IR deletion. These results are entirely consistent with the insulin-mediated effect on the IGFBP1 gene expression in liver cells (31). IGFBP1, which is mainly produced by the liver in the adult mice, inhibits IGF-dependent cellular growth in vivo (30,32,33). In addition, adult transgenic mice showed glucose intolerance and fasting hyperglycemia and hyperinsulinemia. However, the hyperinsulinemia observed in IGFBP1 transgenic mice cannot be attributable to insulin resistance alone (34,35). In fact, adult IGFBP1 transgenic mice displayed larger and more numerous beta-cell islets reflecting increased beta-cell proliferation (36). The increase of plasma IGF-1 and IGFBP1 in iLIRKO mice contrasts with IGF-1 decreases and IGFBP1 increases in liver-specific Irs1-/-:Irs2-/- mice, a mouse model also showing beta-cell mass hyperplasia (37). Finally, the levels of IR were increased in the pancreatic islets of iLIRKO as compared with controls. Moreover, we noted an increase in the expression of IR-A versus IR-B in pancreatic islets from iLIRKO mice. Under our experimental conditions, IGF-1-induced proliferation was significantly higher in pancreatic islets from iLIRKO mice than in controls. These data strongly support the notion that increased expression of IR-A relative to IR-B may enhance the growth response of pancreatic beta-cell to IGF-1. Moreover, based on our observations in mouse beta-cell lines, the presence of mostly IR-A in pancreatic islets may cause initially an increase in glucose uptake, a classic mitogenic signal in beta-cells (17) and, subsequently, enhanced proliferation in response to either insulin or IGF-1. Alternatively, an increase in IRS-2 in pancreatic islets from iLIRKO mice may account for their enhanced proliferation in response to IGF-1. Our data obtained in pancreatic islets microarrays from iLIRKO versus control mice rule out that possibility (results not shown). Taken all together, our findings imply that IR-A, but not IR-B, confers a proliferative capacity to beta-cells, which enables them to respond to insulin or IGF-1; this hypothesis may account for the beta-cell hyperplasia induced by liver insulin resistance in iLIRKO mice. Thus, our results in iLIRKO mice seem to suggest a liver-pancreas endocrine axis, whereby increased plasma IGF-1 functions as a liver-derived growth factor to promote compensatory beta-cell hyperplasia through IR-A.
###end p 54
###begin p 55
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 977 981 <span type="species:ncbi:10090">mice</span>
In conclusion, our results demonstrate that hepatic IR deficiency can lead to systemic insulin resistance. Given that insulin resistance states can be compensated for by beta-cell hyperplasia, studies of iLIRKO emphasize a cause-and-effect relationship between progressive insulin resistance and beta-cell hyperplasia. Ultimately, the beta-cells fail to secrete sufficient insulin, and this leads to uncontrolled diabetes. Thus, in iLIRKO mice, hepatic insulin resistance is sufficient to recapitulate the progressive pathogenesis of type 2 diabetes. IGF-1 expression was enhanced depending on the extent of hepatic IR deletion, and this resulted in a persistent increase of circulating IGF-1 in iLIRKO mice. Concurrently, IR-A expression was significantly increased in pancreatic islets of iLIRKO mice, presumably providing a mechanism by which the proliferative response to IGF-I was enhanced in the hyperplastic pancreatic islets of iLIRKO mice. Thus, our studies of iLIRKO mice suggest a liver-pancreas endocrine axis in which IGF-1 functions as a liver factor to promote compensatory beta-cell hyperplasia through IR-A.
###end p 55
###begin p 56
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 56
###begin title 57
Acknowledgments
###end title 57
###begin p 58
This research was supported by grants SAF2005/00014 and SAF2007/60058 from Ministerio de Educacion y Ciencia and Red Tematica de Investigacion Cooperativa en Diabetes and grant RD06/0015/0005 from Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain. CIBER de Diabetes y Enfermedades Metabolicas Asociadas is an ISCIII Project.
###end p 58
###begin p 59
No potential conflicts of interest relevant to this study were reported.
###end p 59
###begin p 60
We thank Dr. Deborah Burks for the English edition of the manuscript and also Gema Garcia and Sylvia Fernandez for technical assistance. We acknowledge the technical expertise of Dr. J.A. Lopez Garcia-Asenjo, Surgery Pathology Branch, Hospital Clinico San Carlos, Madrid, Spain.
###end p 60
###begin title 61
REFERENCES
###end title 61
###begin article-title 62
Banting Lecture: Insulin action, diabetogenes, and the cause of type 2 diabetes.
###end article-title 62
###begin article-title 63
Diabetes: causes of insulin resistance.
###end article-title 63
###begin article-title 64
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse models of insulin resistance.
###end article-title 64
###begin article-title 65
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Insulin receptor knockout mice.
###end article-title 65
###begin article-title 66
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Early neonatal death in mice homozygous for a null allele of the insulin receptor gene.
###end article-title 66
###begin article-title 67
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality.
###end article-title 67
###begin article-title 68
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Transgenic rescue of insulin receptor-deficient mice.
###end article-title 68
###begin article-title 69
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.
###end article-title 69
###begin article-title 70
Role of brain insulin receptor in control of body weight and reproduction.
###end article-title 70
###begin article-title 71
Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.
###end article-title 71
###begin article-title 72
A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.
###end article-title 72
###begin article-title 73
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Inducible gene targeting in mice.
###end article-title 73
###begin article-title 74
IRS-1 and IRS-2 differential signaling in the insulin/IGF-1 pathways in fetal brown adipocytes.
###end article-title 74
###begin article-title 75
Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance.
###end article-title 75
###begin article-title 76
###xml 54 58 <span type="species:ncbi:10116">rats</span>
Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion.
###end article-title 76
###begin article-title 77
Differential mitogenic signaling in insulin receptor-deficient fetal pancreatic beta-cells.
###end article-title 77
###begin article-title 78
###xml 104 119 <span type="species:ncbi:10633">simian virus 40</span>
Role of insulin receptor and balance in insulin receptor isoforms A and B in regulation of apoptosis in simian virus 40-immortalized neonatal hepatocytes.
###end article-title 78
###begin article-title 79
IRS-3 mediates insulin-induced glucose uptake in differentiated IRS-2(-/-) brown adipocytes.
###end article-title 79
###begin article-title 80
###xml 52 55 <span type="species:ncbi:10116">rat</span>
###xml 88 91 <span type="species:ncbi:10116">rat</span>
Insulin receptor substrate-4 signaling in quiescent rat hepatocytes and in regenerating rat liver.
###end article-title 80
###begin article-title 81
Evidence for a circulating islet cell growth factor in insulin-resistant status.
###end article-title 81
###begin article-title 82
###xml 39 44 <span type="species:ncbi:9606">human</span>
Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action.
###end article-title 82
###begin article-title 83
Mosaic analysis of insulin receptor function.
###end article-title 83
###begin article-title 84
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice.
###end article-title 84
###begin article-title 85
Insulin degradation: progress and potential.
###end article-title 85
###begin article-title 86
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Disruption of IRS-2 causes type 2 diabetes in mice.
###end article-title 86
###begin article-title 87
Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance.
###end article-title 87
###begin article-title 88
Circulating levels of IGF-1 directly regulate bone growth and density.
###end article-title 88
###begin article-title 89
beta-Cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass.
###end article-title 89
###begin article-title 90
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins.
###end article-title 90
###begin article-title 91
Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.
###end article-title 91
###begin article-title 92
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 83 98 <span type="species:ncbi:10090">transgenic mice</span>
Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth.
###end article-title 92
###begin article-title 93
###xml 85 100 <span type="species:ncbi:10090">transgenic mice</span>
Growth retardation and hyperglycemia in insulin like growth factor binding protein-1 transgenic mice.
###end article-title 93
###begin article-title 94
###xml 93 108 <span type="species:ncbi:10090">transgenic mice</span>
Hyperglycemia and impaired glucose tolerance in insulin-like growth factor binding protein-1 transgenic mice.
###end article-title 94
###begin article-title 95
###xml 77 92 <span type="species:ncbi:10090">transgenic mice</span>
Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice.
###end article-title 95
###begin article-title 96
###xml 90 105 <span type="species:ncbi:10090">transgenic mice</span>
Islet cell proliferation and apoptosis in insulin-like growth factor binding protein-1 in transgenic mice.
###end article-title 96
###begin article-title 97
Inactivation of hepatic foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation.
###end article-title 97

